In vitro assay reveals potent alpha-glucosidase and tyrosinase inhibition by Castanopsis lamontii constituents, suggesting therapeutic potential for metabolic disorders and hyperpigmentation.
Phytochemical investigation of the mature leaves of Castanopsis lamontii, an underexplored traditional folk medicine, led to the isolation of two new phenolic derivatives, lamontin B (1) and 6-O-(5-O-methylgalloyl)-D-glucopyranose (2) and eleven known compounds. Their structures were elucidated through extensive spectroscopic analysis. Bioactivity assays revealed that kaempferol (10), quercetin (11), and castanopsinin E (13) exhibited potent α-glucosidase inhibitory activities (IC50: 0.03–0.15 mM), which were significantly more active than the positive control acarbose (IC50: 1.5 mM). Furthermore, isodehydrodigallic acid (4), 10, and 11 displayed significant tyrosinase inhibition (IC50: 0.32–0.61 mM), surpassing kojic acid (IC50: 0.83 mM). Structure-activity relationship analysis suggested that the C-28 glycosylation in triterpenoid ellagitannins and the B-ring catechol moiety in flavonoids are pivotal for their α-glucosidase inhibition.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: